$44.34
1.212.81%
Últ. Act.: Oct 30, 6:49 PM
Sanofi (SNY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Sanofi (SNY) publicó su última previsión de julio 30, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $55.79B - $55.79B para el período.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.63 | $1.09 | $1.06 | $0.84 |
| Actual | $2.04 | $1.21 | $1.10 | $0.89 |
| Surprise | +25.3% | +11.4% | +3.77% | +5.95% |
| Revenue | ||||
| Estimate | $15.23B | $12.65B | $11.99B | $13.41B |
| Actual | $16.62B | $13.48B | $12.31B | $13.16B |
| Surprise | +9.15% | +6.58% | +2.64% | -1.87% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.07 | $1.14 | $1.29 | $1.84 |
| Revenue | ||||
| Consensus | $14.38B | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 30, 2026 | $2.04 | $1.63 | 25.3 % |
| Q2 | Jul 30, 2026 | $1.21 | $1.09 | 11.4 % |
| Q1 | Apr 23, 2026 | $1.10 | $1.06 | 3.77 % |
| Q4 | Jan 29, 2026 | $0.89 | $0.84 | 5.95 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 30, 2026 | $16.62B | $15.23B | 9.15 % |
| Q2 | Jul 30, 2026 | $13.48B | $12.65B | 6.58 % |
| Q1 | Apr 23, 2026 | $12.31B | $11.99B | 2.64 % |
| Q4 | Jan 29, 2026 | $13.16B | $13.41B | -1.87 % |